Some users experience fluctuations in blood sugar overnight, which can lead to wakefulness, restlessness, or early morning anxiety
doi: 10.1152/japplphysiol.00855.2015, 153
Successful medical management of status post-Roux-en-Y-gastric-bypass hyperinsulinemic hypoglycemia
Treatment typically involves lifestyle changes, but there are also drug treatments like Wegovy (semaglutide), an injectable GLP-1 medication that is FDA-approved for chronic weight management due to its effectiveness in lowering blood sugar and decreasing appetite
The product information update is regarding Glucagon-Like Peptide-1 receptor agonists or dual GLP-1/ glucose-dependent insulinotropic polypeptide (GIP) receptor agonists, commonly known as GLP-1s
Didnt find the Answer you were looking for